# A Study of Two Different Formulations of LY3502970 in Healthy Participants

> **NCT05341089** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 39 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3502970

## Key facts

- **NCT ID:** NCT05341089
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-17
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05341089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05341089, "A Study of Two Different Formulations of LY3502970 in Healthy Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05341089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*